当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析

方盛制药

(603998)

  

流通市值:49.92亿  总市值:50.51亿
流通股本:4.34亿   总股本:4.40亿

方盛制药(603998)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.68亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益165836.07万元,未分配利润78613.23万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产325382.81万元,负债159546.74万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入438,354,992.771,628,542,252.041,214,912,885.84855,215,463.45
营业总成本376,020,762.611,474,391,400.571,075,791,850.72754,315,876.01
营业利润79,004,804.68196,445,611.18159,335,085.01122,025,586.58
利润总额78,990,611.87203,338,297.11158,514,675.04121,307,688.34
净利润68,264,902.22179,623,902.46140,619,211.55106,068,426.92
其他综合收益----
综合收益总额68,264,902.22179,623,902.46140,619,211.55106,068,426.92
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,040,737,121.39920,669,331.891,144,717,915.361,138,248,104.97
非流动资产合计2,213,090,976.372,160,316,337.471,959,724,296.651,902,973,827.41
资产总计3,253,828,097.763,080,985,669.363,104,442,212.013,041,221,932.38
流动负债合计1,223,063,954.651,248,089,199.521,147,397,714.351,088,876,818.91
非流动负债合计372,403,462.06244,170,485.18394,241,000.55425,543,382.88
负债合计1,595,467,416.711,492,259,684.71,541,638,714.91,514,420,201.79
归属于母公司股东权益合计1,531,765,308.651,458,093,676.181,422,821,307.291,395,986,764.12
股东权益合计1,658,360,681.061,588,725,984.661,562,803,497.111,526,801,730.59
负债和股东权益合计3,253,828,097.763,080,985,669.363,104,442,212.013,041,221,932.38
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计428,136,924.21,741,191,132.881,262,503,197.64827,755,943.36
经营活动现金流出小计381,238,666.061,653,653,190.081,274,015,254.34882,616,624.28
经营活动产生的现金流量净额46,898,258.1487,537,942.8-11,512,056.7-54,860,680.92
投资活动现金流入小计33,209,624.69173,786,909.3122,855,661.1495,824,729.79
投资活动现金流出小计61,857,335.88371,189,378.72293,279,038.54187,167,092.08
投资活动产生的现金流量净额-28,647,711.19-197,402,469.42-170,423,377.4-91,342,362.29
筹资活动现金流入小计317,620,000521,881,950421,259,622.77278,231,950
筹资活动现金流出小计268,076,147.74613,429,268.39458,890,956.58350,538,128.95
筹资活动产生的现金流量净额49,543,852.26-91,547,318.39-37,631,333.81-72,306,178.95
汇率变动对现金及现金等价物的影响-1.881.881.88
现金及现金等价物净增加额67,794,399.21-201,411,843.13-219,566,766.03-218,509,220.28
期末现金及现金等价物余额249,825,449.24182,031,050.03163,876,127.13164,933,672.88
最新报告期:2024-04-23
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国海证券周小刚,沈岽皓0.670.690.892024-04-23
东方财富证券何玮0.600.690.772024-04-23
东吴证券朱国广0.550.710.902024-04-23
海通证券郑琴,余文心0.390.520.682024-02-08
TOP↑